SensTrain Clinical Research Receives 1851 Commission Funding!

We’re proud to celebrate an exciting achievement in the field of phantom limb pain (PLP) research. Sarah Oatway, Clinical Trial Manager for the ongoing study on two new SensTrain device variants, has been awarded funding from the prestigious Royal Commission for the Exhibition of 1851. Established in 1851 by Prince Albert to administer the Great Exhibition, this foundation supports scientific research and industrial innovation, funding projects that drive technological advancements with real-world impact.

The funding supports further research into innovative SensTrain variants, helping to refine and expand the therapy’s capabilities. While these trial devices differ from the commercially available SensTrain Neuro-PL, they share the same fundamental goal—helping individuals retrain their brains and reduce PLP through precise neurostimulation.

This recognition underscores the growing scientific interest in SensTrain’s approach and its potential to offer lasting relief for those living with PLP. With continued research and development, we are paving the way for more effective, accessible treatments.

Learn More

To read more about Sarah Oatway’s award and the ongoing research, visit the official announcement: Royal Commission 1851.

We’re excited about the future of SensTrain and grateful for the continued support from both the scientific community and PLP sufferers who inspire this work every day!